Sponsor & Developer Portfolio
Monash University
Clinical development pipeline, platform architecture, and registered trial tracking for Monash University vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 1
Platform Technologies
mRNA: 1
Target Pathogens & Indications
COVID-19
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 3 Clinical Trial
ctgov-pfizer-bivalent-covid-19-vaccine-monash-university
Moderna Bivalent mRNA vaccine
Target: COVID-19
Platform: mRNA
Key Milestone: Primary completion (most advanced trial): 2026-06-30 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.